Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.
Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.
The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.
Publications found:
71,946
Sort by:
POEMS Syndrome (Crow-Fukase Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
POEMS Syndrome (Crow-Fukase Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY POEMS Syndrome (Crow-Fukase Syndrome) Drugs in Development by Stages, Targ...
May 2022
39 pages
Pol Polyprotein Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
US$ 2,500.00
Pol Polyprotein Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Pol Polyprotein Drugs in Development by Therapy Areas and Indications, St...
May 2022
41 pages
Polymyositis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Polymyositis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Polymyositis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...
May 2022
38 pages
Polyomavirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Polyomavirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Polyomavirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...
May 2022
57 pages
Post Operative Nausea And Vomiting Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Post Operative Nausea And Vomiting Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Post Operative Nausea And Vomiting Drugs in Development by Stages, Target, Mo...
May 2022
38 pages
Posterior Uveitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Posterior Uveitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Posterior Uveitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...
May 2022
45 pages
Postherpetic Neuralgia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Postherpetic Neuralgia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Postherpetic Neuralgia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...
May 2022
50 pages
Postoperative Ileus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Postoperative Ileus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Postoperative Ileus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...
May 2022
36 pages
Pouchitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Pouchitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pouchitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an...
May 2022
41 pages
Pre-Eclampsia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Pre-Eclampsia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pre-Eclampsia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...
May 2022
42 pages
Premature Ovarian Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Premature Ovarian Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Premature Ovarian Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule T...
May 2022
39 pages
Primary Ciliary Dyskinesia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Primary Ciliary Dyskinesia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Primary Ciliary Dyskinesia Drugs in Development by Stages, Target, MoA, RoA, Molecule...
May 2022
41 pages
Primary CNS Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Primary CNS Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Primary CNS Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Ke...
May 2022
55 pages
Primary Hyperoxaluria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Primary Hyperoxaluria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Primary Hyperoxaluria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and...
May 2022
44 pages
Primary Hyperoxaluria Type I Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Primary Hyperoxaluria Type I Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Primary Hyperoxaluria Type I Drugs in Development by Stages, Target, MoA, RoA, Mole...
May 2022
38 pages
Primary Mediastinal B-Cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Primary Mediastinal B-Cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Primary Mediastinal B-Cell Lymphoma Drugs in Development by Stages, Target,...
May 2022
129 pages
Primitive Neuroectodermal Tumor (PNET) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Primitive Neuroectodermal Tumor (PNET) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Primitive Neuroectodermal Tumor (PNET) Drugs in Development by Stages, Ta...
May 2022
43 pages
Proctitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Proctitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Proctitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an...
May 2022
37 pages
Propionic Acidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Propionic Acidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Propionic Acidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...
May 2022
41 pages
